Sort
8,912 grants matching “sars cov 2”
Anchimerically Activatable Anti-Zika/Dengue ProTides
$670,946Carston R. Wagner · University Of Minnesota · R01 · FY2021 · AI
Surveillance genome sequencing to detect SARS-CoV-2 virus variants in Montana
$670,730Bruce E Bowler · University Of Montana · P30 · FY2022 · GM
Cerebral Energy Metabolism in ME/CFS with and without PASC
$670,721Xiang Xu · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS
Covid-19 Effects on Children & Families: 2021 Follow-Up of the PSID Child Development Supplement
$670,627Narayan Sastry · University Of Michigan At Ann Arbor · R01 · FY2023 · HD
Longitudinal study of health outcomes and mitigating factors in the aftermath of the COVID pandemic
$670,624Manoj Mohanan · Duke University · R01 · FY2023 · HD
Mass Spectrometry Identification
$670,590Jason Williams · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Phylodynamics of emerging infectious disease threats
$670,520Martha Nelson · National Library Of Medicine · ZIA · FY2025 · LM
Determinants of Early Childhood Immune Responses to SARS-CoV-2 Vaccination
$670,481Mary Prahl · University Of California, San Francisco · R01 · FY2023 · HD
Role of Hyaluronan in IL-13-mediated COVID-19 Pathology
$670,452William A Petri · University Of Virginia · R01 · FY2024 · HL
Olfactory mucosa repair and defense: neuro-immune mechanisms and therapy
$670,166Andrew P Lane · Johns Hopkins University · R01 · FY2023 · DC
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
$669,976Lisa Goldman Rosas · Stanford University · R01 · FY2021 · MD
Research Project 1 - The pregnancy ImmunOME
$669,960Andrea Goldberg Edlow · Massachusetts Institute Of Technology · U19 · FY2024 · AI
Digital Health and Health Disparities Research Lab
$669,672Sherine El-Toukhy · National Institute On Minority Health And Health Disparities · ZIA · FY2023 · MD
Unconventional protein secretion-mediated protein quality control in health and diseases
$669,370Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Covid-19 Effects on Children & Families: 2021 Follow-Up of the PSID Child Development Supplement
$668,825Narayan Sastry · University Of Michigan At Ann Arbor · R01 · FY2025 · HD
Examining COVID-19 in Down Syndrome Patients Using Human iPSC-Derived Organoids
$668,755Joseph C Wu · Stanford University · R01 · FY2021 · HL
Regulation of germinal center responses by SARS-CoV-2 messenger RNA vaccines
$668,622Michela Locci · University Of Pennsylvania · R01 · FY2024 · AI
Regulation of germinal center responses by SARS-CoV-2 messenger RNA vaccines
$668,622Michela Locci · University Of Pennsylvania · R01 · FY2023 · AI
Characterization and optimization of single dose, thermostable and durable vaccine platform towards increased clinical acceptance
$668,569Nerea Zabaleta · Schepens Eye Research Institute · R01 · FY2024 · AI
NIAID VIROLOGY QUALITY ASSURANCE (VQA) COVID-19
$668,265Thomas Denny · Duke University · N01 · FY2020 · AI
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
$668,250Sixto Manuel Leal · University Of Alabama At Birmingham · R56 · FY2022 · AI
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
$668,126Rebecca Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patients
$667,628Heidi M. Crane · University Of Washington · R01 · FY2025 · HL
An Integrated Host-Microbe Gene Classifier to Predict SARS-CoV-2 and Severe Disease in Children with Respiratory Viral Coinfections
$667,609Joshua Kennedy · Arkansas Children'S Hospital Res Inst · R01 · FY2025 · HL
Determinants of Early Childhood Immune Responses to SARS-CoV-2 Vaccination
$667,362Mary Prahl · University Of California, San Francisco · R01 · FY2024 · HD